Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Sharp, Lail, Donfield, Gomperts, Simmonds: "Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates." dans: Transfusion, Vol. 52, Issue 7, pp. 1482-9, (2012) (PubMed).